199 related articles for article (PubMed ID: 8781447)
1. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations.
Wood BL; Gibson DF; Tait JF
Blood; 1996 Sep; 88(5):1873-80. PubMed ID: 8781447
[TBL] [Abstract][Full Text] [Related]
2. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V.
Kuypers FA; Lewis RA; Hua M; Schott MA; Discher D; Ernst JD; Lubin BH
Blood; 1996 Feb; 87(3):1179-87. PubMed ID: 8562945
[TBL] [Abstract][Full Text] [Related]
3. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia.
de Jong K; Emerson RK; Butler J; Bastacky J; Mohandas N; Kuypers FA
Blood; 2001 Sep; 98(5):1577-84. PubMed ID: 11520810
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure.
Kean LS; Brown LE; Nichols JW; Mohandas N; Archer DR; Hsu LL
Exp Hematol; 2002 May; 30(5):394-402. PubMed ID: 12031645
[TBL] [Abstract][Full Text] [Related]
5. Detection of phosphatidylserine surface exposure on human erythrocytes using annexin V-ferrofluid.
Geldwerth D; Helley D; de Jong K; Sabolovic' D; Sestier C; Roger J; Pons JN; Freyssinet JM; Devaux PF; Kuypers FA
Biochem Biophys Res Commun; 1999 Apr; 258(1):199-203. PubMed ID: 10222260
[TBL] [Abstract][Full Text] [Related]
6. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
7. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes.
de Jong K; Geldwerth D; Kuypers FA
Biochemistry; 1997 Jun; 36(22):6768-76. PubMed ID: 9184159
[TBL] [Abstract][Full Text] [Related]
8. Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V.
Tait JF; Smith C; Wood BL
Blood Cells Mol Dis; 1999; 25(5-6):271-8. PubMed ID: 10744422
[TBL] [Abstract][Full Text] [Related]
9. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.
Wang RH; Phillips G; Medof ME; Mold C
J Clin Invest; 1993 Sep; 92(3):1326-35. PubMed ID: 7690777
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
11. Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells.
Haynes J; Obiako B; King JA; Hester RB; Ofori-Acquah S
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1679-85. PubMed ID: 16714363
[TBL] [Abstract][Full Text] [Related]
12. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
Lang KS; Roll B; Myssina S; Schittenhelm M; Scheel-Walter HG; Kanz L; Fritz J; Lang F; Huber SM; Wieder T
Cell Physiol Biochem; 2002; 12(5-6):365-72. PubMed ID: 12438773
[TBL] [Abstract][Full Text] [Related]
13. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding.
Tait JF; Gibson D
J Lab Clin Med; 1994 May; 123(5):741-8. PubMed ID: 8195679
[TBL] [Abstract][Full Text] [Related]
14. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.
Schwartz RS; Tanaka Y; Fidler IJ; Chiu DT; Lubin B; Schroit AJ
J Clin Invest; 1985 Jun; 75(6):1965-72. PubMed ID: 4008648
[TBL] [Abstract][Full Text] [Related]
15. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion.
Setty BN; Kulkarni S; Stuart MJ
Blood; 2002 Mar; 99(5):1564-71. PubMed ID: 11861269
[TBL] [Abstract][Full Text] [Related]
16. Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.
Zahedpanah M; Azarkeivan A; Aghaieepour M; Nikogoftar M; Ahmadinegad M; Hajibeigi B; Tabatabaiee MR; Maghsudlu M
Hematology; 2014 Dec; 19(8):472-6. PubMed ID: 24620948
[TBL] [Abstract][Full Text] [Related]
17. Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo.
Hassoun H; Wang Y; Vassiliadis J; Lutchman M; Palek J; Aish L; Aish IS; Liu SC; Chishti AH
Blood; 1998 Sep; 92(5):1785-92. PubMed ID: 9716609
[TBL] [Abstract][Full Text] [Related]
18. Propensity of red blood cells to undergo P2X7 receptor-mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging.
Sophocleous RA; Mullany PR; Winter KM; Marks DC; Sluyter R
Transfusion; 2015 Aug; 55(8):1946-54. PubMed ID: 25823581
[TBL] [Abstract][Full Text] [Related]
19. Changes of phosphatidylserine distribution in human red blood cells during the process of loading sugars.
Quan GB; Liu MX; Ren SP; Zhang JG; Han Y
Cryobiology; 2006 Aug; 53(1):107-18. PubMed ID: 16762335
[TBL] [Abstract][Full Text] [Related]
20. Regulation and function of transbilayer movement of phosphatidylserine in activated blood platelets and sickle cells.
Zwaal RF; Bevers EM; Rosing J
Prog Clin Biol Res; 1988; 282():181-92. PubMed ID: 3071796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
